Strategies to develop vaccines of pediatric interest

作者: Susanna Esposito , Nicola Principi

DOI: 10.1080/14760584.2017.1237875

关键词:

摘要: ABSTRACTIntroduction: The success of the vaccines available on market has significantly increased interest in vaccine development.Areas covered: main aim this paper is to discuss most important pediatric that are currently being developed. New pneumococcal and against group B Streptococcus, Staphylococcus aureus respiratory syncytial virus analyzed detail.Expert commentary: Advances understanding human immunology, including monoclonal antibody identification, sequencing technology, ability solve atomic level structures targets have provided tools guide rational design future vaccines. It likely some these will reach thus partially contribute prevention very severe diseases affect morbidity mortality children. However, further studies animals several clinical trials children must be performed before ...

参考文章(126)
Caroline B. Hall, Eric A. F. Simőes, Larry J. Anderson, Clinical and Epidemiologic Features of Respiratory Syncytial Virus Current Topics in Microbiology and Immunology. ,vol. 372, pp. 39- 57 ,(2013) , 10.1007/978-3-642-38919-1_2
Ruth A. Karron, Ursula J. Buchholz, Peter L. Collins, Live-Attenuated Respiratory Syncytial Virus Vaccines Current Topics in Microbiology and Immunology. ,vol. 372, pp. 259- 284 ,(2013) , 10.1007/978-3-642-38919-1_13
Amy Parker Fiebelkorn, Paul A. Gastanaduy, Gregory S. Wallace, Susan B. Redd, Nakia S. Clemmons, Measles - United States, January 4-April 2, 2015. Morbidity and Mortality Weekly Report. ,vol. 64, pp. 373- 376 ,(2015)
Luke Anthony Jardine, Paul Trafford Heath, Neonatal infections: group B streptococcus BMJ clinical evidence. ,vol. 2010, pp. 0323- ,(2010)
Susanna Esposito, Claudia Tagliabue, Samantha Bosis, Meningococcal B Vaccination (4CMenB) in Infants and Toddlers Clinical & Developmental Immunology. ,vol. 2015, pp. 402381- 402381 ,(2015) , 10.1155/2015/402381